Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review

Marjenberg, Zoe; Wright, Ciara; Pooley, Nick; Cheung, KW; Shimakawa, Yusuke; Vargas-Zambrano, Juan C.; Vidor, Emmanuel

doi:10.1016/j.ijid.2022.09.003

Cited by 11 publications

(7 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A single intravenous infusion of infliximab 300 mg (5 mg/kg body weight) was effective therapy for a von Zumbusch pustular flare with neutrophilic cholangitis, presenting with transaminitis of ALT 682 U/L (normal range 14–54), AST 309 U/L (15–41), ALP 347 U/L (38–126). There was normalisation of the liver enzymes day 6 post‐infliximab administration 20 .…”

Section: Resultsmentioning

confidence: 99%

“…Hepatitis B virus (HBV) is endemic in Southeast Asia where there is a higher prevalence of GPP. The seroprevalence of HBsAg in the South East Asia and Western Pacific Regions was reported to be as high as 27.4% 22 . Mother‐to‐child transmission rates were 0.0%–5.2% in infants of mothers who were hepatitis B e antigen‐negative and up to 53.0% in infants of mothers who were hepatitis B e antigen‐positive 22 .…”

Section: Resultsmentioning

confidence: 99%

“…The seroprevalence of HBsAg in the South East Asia and Western Pacific Regions was reported to be as high as 27.4% 22 . Mother‐to‐child transmission rates were 0.0%–5.2% in infants of mothers who were hepatitis B e antigen‐negative and up to 53.0% in infants of mothers who were hepatitis B e antigen‐positive 22 . The causal relationship between GPP and hepatitis B remains to be further determined.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis

Lim

Oon

2023

Experimental Dermatology

View full text Add to dashboard Cite

Generalised pustular psoriasis is a rare and severe form of pustular psoriasis. It was first described by Leopold von Zumbusch in 1910. 1 In 2017, The European Rare and Severe Psoriasis Expert Network (ERASPEN) classified pustular psoriasis into three phenotypes, namely generalised pustular psoriasis (GPP), acrodermatitis continua of Hallopeau and palmoplantar pustulosis. 2 GPP is defined by persisting or relapsing macroscopically visible sterile primary pustules occurring on non-acral skin and not within psoriasis plaques. The Japanese guidelines in 2018 diagnose GPP based on four primary parameters: (a) systemic symptoms such as fever and fatigue; (b) systemic or extensive flush accompanied by multiple sterile pustules that sometimes merge to form lakes of pus; (c) neutrophilic subcorneal pustules histopathologically characterised by Kogoj's spongiform pustules; and (d) recurrence of the described clinical and histological features. 3 A definite diagnosis of GPP is made with the presence of all four criteria.The prevalence of GPP is higher in Asians (7.46 per million in Japan) 4 compared to the Caucasian population (1.76 per million in France 5 and 3.8 per 100 000 in Sweden). 6 There is a female preponderance for GPP and the mean age at onset of GPP was 40.9 years. 7

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis

Lim

Oon

2023

Experimental Dermatology

View full text Add to dashboard Cite

show abstract

“…As mentioned above, genotype I, therefore, represents the stable and successful outcome of recombination events, allowing its classification as a bona fide genotype. Recombination events are, by definition, restricted to the patient where they occur, then to a cluster of individuals belonging to the same family, notably in Eastern Asia, where pseudo-vertical or perinatal transmissions from mothers to newborns are very frequent [ 14 ]. The status of genotype I contrasts with other stable recombinant forms of the HBV that are commonly transmitted and successfully spread in specific populations, albeit without reaching so far as to attain the status of a genotype.…”

Section: Genotype I As a True Genotypementioning

confidence: 99%

Concealed for a Long Time on the Marches of Empires: Hepatitis B Virus Genotype I

Marchio,

Sitbounlang,

Deharo

et al. 2023

Microorganisms

View full text Add to dashboard Cite

Genotype I, the penultimate HBV genotype to date, was granted the status of a bona fide genotype only in the XXIst century after some hesitations. The reason for these hesitations was that genotype I is a complex recombinant virus formed with segments from three original genotypes, A, C, and G. It was estimated that genotype I is responsible for only an infinitesimal fraction (<1.0%) of the chronic HBV infection burden worldwide. Furthermore, most probably due to its recent discovery and rarity, the natural history of infection with genotype I is poorly known in comparison with those of genotypes B or C that predominate in their area of circulation. Overall, genotype I is a minor genotype infecting ethnic minorities. It is endemic to the Southeast Asian Massif or Eastern Zomia, a vast mountainous or hilly region of 2.5 million km2 spreading from Eastern India to China, inhabited by a little more than 100 million persons belonging primarily to ethnic minorities speaking various types of languages (Tibeto-Burman, Austroasiatic, and Tai-Kadai) who managed to escape the authority of central states during historical times. Genotype I consists of two subtypes: I1, present in China, Laos, Thailand, and Vietnam; and I2, encountered in India, Laos, and Vietnam.

show abstract

“…Hepatitis B virus (HBV) damages the liver through acute and chronic infection, with most of the morbidity and mortality arising from the long-term consequences of the infection, mainly due to cirrhosis and hepatocellular carcinoma (SHEENA et al, 2022). Hepatitis B remains one of the major public health problems, with the global seroprevalence estimated at 3.9% in 2016, and in 2019, approximately 296 million people were living with chronic infection, with 1.5 million new infections annually (MARJENBERG, 2022).…”

Section: Introductionmentioning

confidence: 99%

Impact of Vaccination Coverage on the Number of Hepatitis B Cases in the State of Pará Between 2010 and 2020

Viana¹,

Mota²,

Santos³

et al. 2023

JHS

View full text Add to dashboard Cite

Hepatitis B is a chronic infection with high prevalence and morbidity and mortality worldwide, with cases progressing to cirrhosis and hepatocellular carcinoma. However, it is immunopreventable, achieving good vaccination coverage rates when the vaccination plan is correctly used. Thus, studies are needed that correlate the vaccination status and the incidence of hepatitis B cases. The study analyzed the vaccination status in comparison with the number of notified cases of hepatitis B in the state of Pará, in the period between 2010 and 2020, from of data obtained from the DATASUS platform. In general, during the analysis period, the state of Pará was below the vaccination coverage rate set as a goal by the Ministry of Health of 95%, ranging from 100.64% to 55.54%, especially in 2020 (only 55, 54%), with an impact on the period with an increase in cases of hepatitis B, especially among women. The biggest drops in coverage rates were among children (81.63%-55.25%) and the smallest among those aged 15-19 years. It was also observed that Pará was below the disease detection rates (5.2 -1.9) when compared to the rates in the North Region (18.8 -5.5) and by the national parameter (8.4 -2.9). There are several gaps in the data obtained, such as stratification by age group and underreporting of cases, a fact more observed in the years coinciding with the COVID-19 pandemic, creating an obstacle for a more accurate analysis. During the analysis period, vaccination coverage was deficient at all ages, which possibly favored the increase in the case detection rate. In addition, a higher incidence of the disease in the female public was evidenced. There is a need to update the data on the platform, as well as greater rigor in the notification and control of vaccine and disease data, in order to guarantee more appropriate health interventions, such as advertising campaigns.

show abstract

Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review

Cited by 11 publications

References 96 publications

Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis

Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis

Concealed for a Long Time on the Marches of Empires: Hepatitis B Virus Genotype I

Impact of Vaccination Coverage on the Number of Hepatitis B Cases in the State of Pará Between 2010 and 2020

Contact Info

Product

Resources

About